Atlas Trials

A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets

Clinical trial NCT06024915 · COMPLETED

Trial details

NCT number
NCT06024915
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelofibrosis
Start date
2023-09-21
Primary completion
2024-01-29
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.